UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Age associated differences in prevalence of individual rotterdam criteria and metabolic risk factors during reproductive age in 446 caucasian women with polycystic ovary syndrome

Hormone and metabolic research, 2012-09, Vol.44 (9), p.694-698

2012

Volltextzugriff (PDF)

Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome

Journal of endocrinological investigation, 2013-07, Vol.36 (7), p.460-465

2013

Volltextzugriff (PDF)

Antipsychotic treatment for children and adolescents with schizophrenia spectrum disorders: protocol for a network meta-analysis of randomised trials

BMJ open, 2014-10, Vol.4 (10), p.e005708-e005708

2014

Volltextzugriff (PDF)

Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life

Fertility and sterility, 2017-03, Vol.107 (3), p.788-795.e2

2017

Volltextzugriff (PDF)

O-315 Familial endocrine disease increases the risk of pregnancy loss and recurrent pregnancy loss– a nationwide register-based study of 366,548 Danish women

Human reproduction (Oxford), 2024-07, Vol.39 (Supplement_1)

2024

Volltextzugriff (PDF)

Prospective risk of Type 2 diabetes in 99 892 Nordic women with polycystic ovary syndrome and 446 055 controls: national cohort study from Denmark, Finland, and Sweden

Human reproduction (Oxford), 2024-08, Vol.39 (8), p.1823-1834

2024

Volltextzugriff (PDF)

Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome

Human reproduction (Oxford), 2014-08, Vol.29 (8), p.1773-1779

2014

Volltextzugriff (PDF)

The prevalence of Type 2 diabetes is not increased in normal-weight women with PCOS

Human reproduction (Oxford), 2017-11, Vol.32 (11), p.2279-2286

2017

Volltextzugriff (PDF)

Prevalence and incidence of clinically diagnosed knee, hip and hand osteoarthritis in women with polycystic ovary syndrome: a National Register-Based Study

Osteoarthritis and cartilage, 2018-04, Vol.26, p.S200-S200

2018

Volltextzugriff (PDF)

F417 GROUP COUNSELLING AND PHYSICAL ACTIVITY OF PATIENTS WITH POLYCYSTIC OVARIAL SYNDROME (PCOS)

European journal of pain supplements, 2011-09, Vol.5 (1), p.156-156

2011

Volltextzugriff (PDF)

Should we individualize lipid profiling in women with polycystic ovary syndrome?

Human reproduction (Oxford), 2016-12, Vol.31 (12), p.2791-2795

2016

Volltextzugriff (PDF)

Higher blood pressure in normal weight women with PCOS compared to controls

Endocrine Connections, 2021-02, Vol.10 (2), p.154-163

2021

Volltextzugriff (PDF)

Should we individualize lipid profiling in women with polycystic ovary syndrome?

Human reproduction (Oxford), 2017-04, Vol.32 (4), p.966-966

2017

Volltextzugriff (PDF)

Overweight in polycystic ovary syndrome. An update on evidence based advice on diet, exercise and metformin use for weight loss

Minerva endocrinologica, 2013-03, Vol.38 (1), p.59

2013

Volltextzugriff (PDF)

Prescription of antidepressants is increased in D anish patients with polycystic ovary syndrome and is associated with hyperandrogenism. A population‐based cohort study

Clinical endocrinology (Oxford), 2014-06, Vol.80 (6), p.884-889

2014

Volltextzugriff (PDF)

Systematic genetic screening in a prospective group of Danish patients with pheochromocytoma

Research and reports in urology, 2017-01, Vol.9, p.113-119

2017

Volltextzugriff (PDF)

Mitochondrial respiratory function is decreased in skeletal muscles of patients with type 2 diabetes

DIABETOLOGIA, 2006, Vol.49, p.121

2006

Volltextzugriff (PDF)

Osteoarthritis

Ugeskrift for læger, 2002-08, Vol.164 (33), p.3875; author reply 3875

2002

Volltextzugriff (PDF)

e-Dietician in General Practice

2010 Second International Conference on eHealth, Telemedicine, and Social Medicine, 2010, p.29-32

2010

Volltextzugriff (PDF)

Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care: does the choice of biological therapy matter?

Annals of the rheumatic diseases, 2021-11, Vol.80 (11), p.1445-1452

2021

Volltextzugriff (PDF)

Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries

Annals of the rheumatic diseases, 2023-06, Vol.82 (6), p.820-828

2023

Volltextzugriff (PDF)

Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration

Annals of the rheumatic diseases, 2021-11, Vol.80 (11), p.1410-1418

2021

Volltextzugriff (PDF)

Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries

Rheumatology (Oxford, England), 2023-02, Vol.62 (2), p.647-658

2023

Volltextzugriff (PDF)

Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis

Rheumatology (Oxford, England), 2021, Vol.60 (8), p.3635-3645

2021

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Aktive Filter

ThemaMale

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(71)
Tagungsberichte
(5)

Sprache

Englisch
(75)
Dänisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Age associated differences in prevalence of individual rotterdam criteria and metabolic risk factors during reproductive age in 446 caucasian women with polycystic ovary syndrome

Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome

Antipsychotic treatment for children and adolescents with schizophrenia spectrum disorders: protocol for a network meta-analysis of randomised trials

Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life

O-315 Familial endocrine disease increases the risk of pregnancy loss and recurrent pregnancy loss– a nationwide register-based study of 366,548 Danish women

Prospective risk of Type 2 diabetes in 99 892 Nordic women with polycystic ovary syndrome and 446 055 controls: national cohort study from Denmark, Finland, and Sweden

Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome

The prevalence of Type 2 diabetes is not increased in normal-weight women with PCOS

Prevalence and incidence of clinically diagnosed knee, hip and hand osteoarthritis in women with polycystic ovary syndrome: a National Register-Based Study

F417 GROUP COUNSELLING AND PHYSICAL ACTIVITY OF PATIENTS WITH POLYCYSTIC OVARIAL SYNDROME (PCOS)

Should we individualize lipid profiling in women with polycystic ovary syndrome?

Higher blood pressure in normal weight women with PCOS compared to controls

Should we individualize lipid profiling in women with polycystic ovary syndrome?

Overweight in polycystic ovary syndrome. An update on evidence based advice on diet, exercise and metformin use for weight loss

Prescription of antidepressants is increased in D anish patients with polycystic ovary syndrome and is associated with hyperandrogenism. A population‐based cohort study

Systematic genetic screening in a prospective group of Danish patients with pheochromocytoma

Mitochondrial respiratory function is decreased in skeletal muscles of patients with type 2 diabetes

Osteoarthritis

e-Dietician in General Practice

Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care: does the choice of biological therapy matter?

Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries

Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration

One‐Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis: Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment Courses

Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries

Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis

Aktive Filter

Suchergebnisse filtern